Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Deciphering O -glycoprotease substrate preferences with O-Pair Search
2022 StandoutNobel
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Interpreting Change Scores of Tests and Measures Used in Physical Therapy
2006 Standout
Cancer statistics, 2024
2024 Standout
Cancer Statistics, 2021
2021 Standout
Functional Gastroduodenal Disorders
2006 Standout
Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment: Challenges for Drug Development?
1999
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Evaluation of Dyspepsia
1997
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
2000 Standout
Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales
2002
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30
1996
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The Generation R Study: design and cohort update 2010
2010 Standout
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
1996 Standout
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
2006 Standout
O-Pair Search with MetaMorpheus for O-glycopeptide characterization
2020 StandoutNobel
Interpreting the significance of changes in health-related quality-of-life scores.
1998 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Helicobacter pylori Infection in Children: Recommendations for Diagnosis and Treatment
2000
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
The development of androgen-independent prostate cancer
2001 Standout
Irritable bowel syndrome
2016 Standout
Validity of four pain intensity rating scales
2011 Standout
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Measuring the multifaceted roles of mucin-domain glycoproteins in cancer
2022 StandoutNobel
What is a clinically meaningful change on the Functional Assessment of Cancer Therapy–Lung (FACT-L) Questionnaire?Results from Eastern Cooperative Oncology Group (ECOG) Study 5592
2002
Revealing the human mucinome
2022 StandoutNobel
Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-prostate instrument
1997
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Glycosylation in health and disease
2019
Epidemiology of constipation in children and adults: A systematic review
2011 Standout
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
2007 Standout
Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer
2008
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Hidradenitis suppurativa
2020 Standout
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
2004 Standout
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
2006 Standout
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Glycosylation Changes in Prostate Cancer Progression
2021
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
Meaningful Change and Responsiveness in Common Physical Performance Measures in Older Adults
2006 Standout
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
2018
Glycoproteomics
2022 StandoutNobel
Assessment of Quality of Life in the Supportive Care Setting of the Big Lung Trial in Non–Small-Cell Lung Cancer
2005
Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain
2003
Hormone Resistance in Prostate Cancer
1998
Functional Gastrointestinal Disorders in Children: An Italian Prospective Survey
2004
New insights into the role of EMT in tumor immune escape
2017
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Trends in oligomannosylation and α1,2-mannosidase expression in human cancers
2021
Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer.
2002
Early Change in Patient-Reported Health During Lung Cancer Chemotherapy Predicts Clinical Outcomes Beyond Those Predicted by Baseline Report: Results From Eastern Cooperative Oncology Group Study 5592
2003
Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35
1999 Standout
Evaluation and Treatment of Functional Constipation in Infants and Children
2013 Standout
Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
2003 Standout
Prostate-Specific Antigen–Based Screening for Prostate Cancer
2018
Phase III Study of Mitoxantrone Plus Low Dose Prednisone Versus Low Dose Prednisone Alone in Patients With Asymptomatic Hormone Refractory Prostate Cancer
2002
Works of Keefe Murphy being referenced
Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.
1994
Helicobacter pylori infection in children
1994
Integrating biomarkers across omic platforms: an approach to improve stratification of patients with indolent and aggressive prostate cancer
2018
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling
2020
The role of epithelial–mesenchymal transition drivers ZEB 1 and ZEB 2 in mediating docetaxel‐resistant prostate cancer
2017
European Randomised Study of Screening for Prostate Cancer ( ERSPC ) risk calculators significantly outperform the Prostate Cancer Prevention Trial ( PCPT ) 2.0 in the prediction of prostate cancer: a multi‐institutional study
2016